Literature DB >> 29254997

Pleiotropic Roles for ZEB1 in Cancer.

Julie Caramel1,2, Maud Ligier1,2, Alain Puisieux3,2.   

Abstract

ZEB1 is a prime element of a network of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible embryonic transdifferentiation program that allows partial or complete transition from an epithelial to a mesenchymal state. Aberrant expression of ZEB1 has been reported in a variety of human cancers, where it is generally believed to foster migration, invasion, and metastasis. Over the past few years, in vitro and in vivo observations have highlighted unsuspected intrinsic oncogenic functions of ZEB1 that impact tumorigenesis from its earliest stages. Located downstream of regulatory processes that integrate microenvironmental signals and directly implicated in feedback loops controlled by miRNAs, ZEB1 appears to be a central switch that determines cell fate. Its expression fosters malignant transformation through the mitigation of critical oncosuppressive pathways and through the conferment of stemness properties. ZEB1 is also a key determinant of cell plasticity, endowing cells with the capacity to withstand an aberrant mitogenic activity, with a profound impact on the genetic history of tumorigenesis, and to adapt to the multiple constraints encountered over the course of tumor development. Cancer Res; 78(1); 30-35. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29254997     DOI: 10.1158/0008-5472.CAN-17-2476

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  106 in total

1.  Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.

Authors:  Brijesh Kumar; Mayuri Prasad; Poornima Bhat-Nakshatri; Manjushree Anjanappa; Maitri Kalra; Natascia Marino; Anna Maria Storniolo; Xi Rao; Sheng Liu; Jun Wan; Yunlong Liu; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2018-07-11       Impact factor: 12.701

2.  CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.

Authors:  Zhen Zhang; Jianjun Li; Yang Ou; Guang Yang; Kaiyuan Deng; Qiong Wang; Zhaoyang Wang; Wenhao Wang; Quansheng Zhang; Hang Wang; Wei Sun; Peiqing Sun; Shuang Yang
Journal:  Signal Transduct Target Ther       Date:  2020-03-11

3.  Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies.

Authors:  Rong Fu; Yi Li; Nan Jiang; Bo-Xue Ren; Chen-Zi Zang; Li-Juan Liu; Wen-Cong Lv; Hong-Mei Li; Stephen Weiss; Zheng-Yu Li; Tao Lu; Zhao-Qiu Wu
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

4.  Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.

Authors:  Lindsay M LaFave; Vinay K Kartha; Sai Ma; Kevin Meli; Isabella Del Priore; Caleb Lareau; Santiago Naranjo; Peter M K Westcott; Fabiana M Duarte; Venkat Sankar; Zachary Chiang; Alison Brack; Travis Law; Haley Hauck; Annalisa Okimoto; Aviv Regev; Jason D Buenrostro; Tyler Jacks
Journal:  Cancer Cell       Date:  2020-07-23       Impact factor: 31.743

5.  RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.

Authors:  Zheyuan Xu; Ran Wang; Xu Li; Limin Yang; Hao Peng; Yang Wang; Ping Wang
Journal:  J Mol Histol       Date:  2021-01-29       Impact factor: 2.611

6.  ZEB1 promotes invasion and metastasis of endometrial cancer by interacting with HDGF and inducing its transcription.

Authors:  Yan-Yi Xiao; Li Lin; Yong-Hao Li; Hui-Ping Jiang; Li-Tong Zhu; Yuan-Run Deng; Dan Lin; Wei Chen; Cheng-Ying Zeng; Li-Jing Wang; Shao-Cheng Chen; Qing-Ping Jiang; Chun-Hua Liu; Wei-Yi Fang; Sui-Qun Guo
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

7.  Ameliorative effects of miR-186 on cisplatin-triggered acute kidney injury via targeting ZEB1.

Authors:  Xiaoyan Xiong; Bo Tang; Tingting Ji; Xiaoying Li; Shoujun Bai
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 8.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

9.  Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.

Authors:  Hong Gao; Xiaosong Sun; Hongdong Wang; Ying Zheng
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

10.  Correlation between Expression of KLF5 and ZEB1 Transcription Factor Genes in Pancreatic Cancer.

Authors:  M V Zinovyeva; L G Nikolaev; L G Kondratyeva; T V Vinogradova; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2018-08-31       Impact factor: 0.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.